SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

SAP

246.35

+0.72%↑

ASML

596.4

-1.11%↓

DSY

27.8

-0.5%↓

STMPA.FR

21.57

-0.78%↓

NOKIA.FI

3.52

-0.28%↓

Kodu・Aktsiate loetelu・Claranova SE

Claranova SE

Suletud

1.964 -4.43

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.932

Max

2.055

Põhinäitajad
By Trading Economics
Sissetulek	10M
Müük	294M
Kasumimarginaal	3.472
Töötajad	772
EBITDA	34M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+82.24% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	29. okt 2025

Turustatistika
By TradingEconomics
Turukapital	143M
Eelmine avamishind	6.39
Eelmine sulgemishind	1.964

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

2.515 / 2.61 Toetus ja vastupanu

Claranova SE Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2025, 21:42 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. aug 2025, 21:21 UTC

Tulu

Suurimad hinnamuutused turgudel

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. aug 2025, 20:45 UTC

Tulu

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. aug 2025, 19:15 UTC

Suurimad hinnamuutused turgudel

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. aug 2025, 21:30 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 21:21 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. aug 2025, 21:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss $938M >RIG

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss/Shr $1.06 >RIG

4. aug 2025, 20:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. aug 2025, 20:15 UTC

Tulu

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. aug 2025, 20:13 UTC

Tulu

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. aug 2025, 20:09 UTC

Tulu

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. aug 2025, 20:06 UTC

Tulu

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Claranova SE Prognoos

Hinnasiht

By TipRanks

82.24% tõus

12 kuu keskmine prognoos

Keskmine 3.9 EUR 82.24%

Kõrge 3.9 EUR

Madal 3.9 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Claranova SE 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Claranova SE aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.515 / 2.61Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

All events are bullish.

Finantsandmed

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Claranova SE

Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally. It operates in three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers photos, frames, personalized books, and FreePrints mobile applications. The Avanquest segment provides antivirus, ad blocker, cleaning, and optimization tools under the Adaware brand; document management tools under the SodaPDF brand; and photo editor software and applications developed under the inPixio brand. The myDevices segment offers IoT solutions. Claranova SE was incorporated in 1984 and is headquartered in Courbevoie, France.